FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034886073> ?p ?o ?g. }

• W2034886073 endingPage "1269" @default.
• W2034886073 startingPage "1262" @default.
• W2034886073 abstract "Calcineurin inhibitors (CNIs) contribute to renal dysfunction following liver transplantation. This prospective, randomized, multicenter, 6-month study (with an additional 6 months of follow-up) evaluated whether everolimus with CNI reduction or discontinuation would improve renal function in maintenance liver transplant recipients experiencing CNI-related renal impairment. Patients started everolimus therapy with CNI reduction or discontinuation (n = 72) or continued receiving standard-exposure CNI (n = 73). At month 6, 80% of the patients who had converted to everolimus had discontinued the CNI. The mean change in creatinine clearance (CrCl) from baseline to month 6 was similar between groups (everolimus, 1.0 ± 10.2 mL/minute; controls, 2.3 ± 7.8 mL/minute; P = 0.46), so the primary study endpoint (8 mL/minute difference in the change in CrCl) was not achieved. Among patients who continued everolimus according to the protocol, the mean increase in CrCl was 2.1 (n = 53) and 3.8 mL/minute (n = 38) at months 6 and 12, respectively, versus 2.4 (n = 68) and 3.5 mL/minute in controls (n = 51). The high frequency of CNI dose reductions in controls (77% of the patients) and the relatively long mean time post-transplant (>3 years) likely contributed to the small difference in CrCl. Biopsy-proven acute rejection occurred in 1.4% of the patients in each group, with no graft losses. Study drug discontinuation was higher in everolimus-treated patients, and adverse events were more frequent. These data demonstrate that everolimus allows for discontinuation or a major reduction of CNI exposure in liver allograft recipients suffering CNI-related renal dysfunction without a loss of efficacy. Trials targeting earlier conversion post-transplantation are required to confirm the efficacy and safety of everolimus for improving renal function after liver transplantation. Liver Transpl 15:1262–1269, 2009. © 2009 AASLD." @default.
• W2034886073 created "2016-06-24" @default.
• W2034886073 creator A5017307697 @default.
• W2034886073 creator A5028707909 @default.
• W2034886073 creator A5039259452 @default.
• W2034886073 creator A5055559412 @default.
• W2034886073 creator A5065733742 @default.
• W2034886073 creator A5066608092 @default.
• W2034886073 creator A5067604095 @default.
• W2034886073 creator A5080844718 @default.
• W2034886073 creator A5090417830 @default.
• W2034886073 creator A5091564657 @default.
• W2034886073 date "2009-09-29" @default.
• W2034886073 modified "2023-10-16" @default.
• W2034886073 title "Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial" @default.
• W2034886073 cites W1550111394 @default.
• W2034886073 cites W1881515087 @default.
• W2034886073 cites W1980200118 @default.
• W2034886073 cites W1986162258 @default.
• W2034886073 cites W1986317438 @default.
• W2034886073 cites W1991996625 @default.
• W2034886073 cites W1995073937 @default.
• W2034886073 cites W2002698162 @default.
• W2034886073 cites W2004366555 @default.
• W2034886073 cites W2012093574 @default.
• W2034886073 cites W2014094846 @default.
• W2034886073 cites W2023332868 @default.
• W2034886073 cites W2028810521 @default.
• W2034886073 cites W2041731912 @default.
• W2034886073 cites W2054910503 @default.
• W2034886073 cites W2057031467 @default.
• W2034886073 cites W2057830383 @default.
• W2034886073 cites W2059225925 @default.
• W2034886073 cites W2072604224 @default.
• W2034886073 cites W2076944363 @default.
• W2034886073 cites W2102724745 @default.
• W2034886073 cites W2117698357 @default.
• W2034886073 cites W2118649964 @default.
• W2034886073 cites W2134672034 @default.
• W2034886073 cites W2144233537 @default.
• W2034886073 cites W2153851381 @default.
• W2034886073 cites W2168638212 @default.
• W2034886073 cites W2221322572 @default.
• W2034886073 cites W2400700345 @default.
• W2034886073 cites W4241498596 @default.
• W2034886073 doi "https://doi.org/10.1002/lt.21827" @default.
• W2034886073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19790150" @default.
• W2034886073 hasPublicationYear "2009" @default.
• W2034886073 type Work @default.
• W2034886073 sameAs 2034886073 @default.
• W2034886073 citedByCount "136" @default.
• W2034886073 countsByYear W20348860732012 @default.
• W2034886073 countsByYear W20348860732013 @default.
• W2034886073 countsByYear W20348860732014 @default.
• W2034886073 countsByYear W20348860732015 @default.
• W2034886073 countsByYear W20348860732016 @default.
• W2034886073 countsByYear W20348860732017 @default.
• W2034886073 countsByYear W20348860732018 @default.
• W2034886073 countsByYear W20348860732019 @default.
• W2034886073 countsByYear W20348860732020 @default.
• W2034886073 countsByYear W20348860732021 @default.
• W2034886073 countsByYear W20348860732022 @default.
• W2034886073 countsByYear W20348860732023 @default.
• W2034886073 crossrefType "journal-article" @default.
• W2034886073 hasAuthorship W2034886073A5017307697 @default.
• W2034886073 hasAuthorship W2034886073A5028707909 @default.
• W2034886073 hasAuthorship W2034886073A5039259452 @default.
• W2034886073 hasAuthorship W2034886073A5055559412 @default.
• W2034886073 hasAuthorship W2034886073A5065733742 @default.
• W2034886073 hasAuthorship W2034886073A5066608092 @default.
• W2034886073 hasAuthorship W2034886073A5067604095 @default.
• W2034886073 hasAuthorship W2034886073A5080844718 @default.
• W2034886073 hasAuthorship W2034886073A5090417830 @default.
• W2034886073 hasAuthorship W2034886073A5091564657 @default.
• W2034886073 hasBestOaLocation W20348860731 @default.
• W2034886073 hasConcept C126322002 @default.
• W2034886073 hasConcept C126894567 @default.
• W2034886073 hasConcept C128057223 @default.
• W2034886073 hasConcept C141071460 @default.
• W2034886073 hasConcept C159641895 @default.
• W2034886073 hasConcept C168563851 @default.
• W2034886073 hasConcept C188816634 @default.
• W2034886073 hasConcept C197934379 @default.
• W2034886073 hasConcept C203092338 @default.
• W2034886073 hasConcept C2775965419 @default.
• W2034886073 hasConcept C2778715236 @default.
• W2034886073 hasConcept C2779609443 @default.
• W2034886073 hasConcept C2779699572 @default.
• W2034886073 hasConcept C2911091166 @default.
• W2034886073 hasConcept C2992435398 @default.
• W2034886073 hasConcept C71924100 @default.
• W2034886073 hasConceptScore W2034886073C126322002 @default.
• W2034886073 hasConceptScore W2034886073C126894567 @default.
• W2034886073 hasConceptScore W2034886073C128057223 @default.
• W2034886073 hasConceptScore W2034886073C141071460 @default.
• W2034886073 hasConceptScore W2034886073C159641895 @default.
• W2034886073 hasConceptScore W2034886073C168563851 @default.
• W2034886073 hasConceptScore W2034886073C188816634 @default.

• next